GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zhejiang Orient Gene Biotech Co Ltd (SHSE:688298) » Definitions » Total Equity

Zhejiang Orient Gene Biotech Co (SHSE:688298) Total Equity : ¥7,051.2 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Zhejiang Orient Gene Biotech Co Total Equity?

Zhejiang Orient Gene Biotech Co's total equity for the quarter that ended in Sep. 2024 was ¥7,051.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Zhejiang Orient Gene Biotech Co Total Equity Historical Data

The historical data trend for Zhejiang Orient Gene Biotech Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Orient Gene Biotech Co Total Equity Chart

Zhejiang Orient Gene Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 254.13 2,451.32 6,888.79 8,322.99 7,549.73

Zhejiang Orient Gene Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,927.05 7,549.73 7,536.82 7,186.77 7,051.23

Zhejiang Orient Gene Biotech Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Zhejiang Orient Gene Biotech Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=8995.951-1446.223
=7,549.7

Zhejiang Orient Gene Biotech Co's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=8234.404-1183.177
=7,051.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Orient Gene Biotech Co Total Equity Related Terms

Thank you for viewing the detailed overview of Zhejiang Orient Gene Biotech Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Orient Gene Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
3787 East Section of Yangguang Avenue, Dipu Street, Anji County, Zhejiang Province, Huzhou, CHN, 313300
Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.

Zhejiang Orient Gene Biotech Co Headlines

No Headlines